Scilex Holding Company
SCLXDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How SCLX's past catalysts played out
Frequently asked questions
What is in Scilex Holding Company's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Scilex Holding Company's (SCLX) pipeline across Phase 3, Phase 2. Its lead program is SP-102 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Scilex Holding Company's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Scilex Holding Company (SCLX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SCLX biotech catalysts?→
Add SCLX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Scilex Holding Company's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.